U.S. Pharma Stock News

Lennox International recently saw board member Sivasankaran Somasundaram resign in May 2026 and is scheduled to present at the 46th Annual William Blair Growth Stock Conference on June 3, 2026, in Chicago. The routine nature of the board change, combined with strong third‑party financial scoring and valuation metrics, has sharpened investor focus on Lennox’s underlying business quality rather than governance concerns. Now, we’ll examine how the strong third‑party financial assessment and...

Recent performance snapshot MarketAxess Holdings (MKTX) has seen its stock retreat, with the price down 21% over the past month and 35% over the past 3 months, closing at US$116.51 most recently. Over longer periods, the stock is also lower, with the year to date return down 35% and the past year and 3 year total returns down 47% and 55% respectively, against a market value of about US$4.1b. See our latest analysis for MarketAxess Holdings. For investors, the picture is one of fading...

Pursuit Attractions and Hospitality recently unveiled Hotel Whitefish, a multi-million-dollar reinvestment transforming Grouse Mountain Lodge in Whitefish, Montana, with phased upgrades to guestrooms, amenities, and an 8,250-square-foot event pavilion running through a full launch targeted for Summer 2027 as part of its broader US$300.00 million growth plan by 2030. This reinvestment signals a clear focus on enhancing higher-yield destination assets and year-round event capacity, potentially...

Recent commentary around Lindblad Expeditions Holdings (LIND) has turned cautious, focusing on its relatively high valuation at a time when competitive pressure, seasonal constraints and fuel exposure are all weighing on sentiment. See our latest analysis for Lindblad Expeditions Holdings. Lindblad’s recent price action reflects this tension, with a 90 day share price return of 26.18% and year to date share price return of 54.22% contrasting with a 1 year total shareholder return of 95.87%...

Ryder System has recently reported stronger contractual business activity, upbeat used vehicle sales and tighter cost controls, supporting an upward revision to its 2026 earnings estimate. These operating gains, alongside ongoing dividends and share buybacks, underline how Ryder’s disciplined capital allocation is shaping its financial profile. We’ll now explore how the upgraded 2026 earnings estimate influences Ryder’s existing investment narrative built around contract growth and...

On 9 June 2026, Unum Group presented at the Morgan Stanley US Financials Conference in New York, following a first quarter in which revenue declined year on year and fell short of analyst expectations. The company’s update comes after a slower quarter for both Unum and the broader life insurance sector, highlighting how management’s commentary and positioning are being assessed against wider industry headwinds. We’ll now examine how Unum’s weaker first-quarter revenue but relatively...

Conference spotlight and recent price slide put AptarGroup in focus AptarGroup (ATR) is in the spotlight as CFO Vanessa Kanu speaks at back to back Jefferies healthcare and Wells Fargo industrials conferences, at the same time that the stock has fallen about 6% over the past month. See our latest analysis for AptarGroup. That recent 6% slide over the month and 12.2% 90 day share price return decline sits against a 1 year total shareholder return down 22.9%, while the 3 year total shareholder...

Star Bulk Carriers (SBLK) is back in focus after reporting Q1 adjusted EPS of $0.56 that surpassed consensus estimates, pairing that result with a $0.50 per share dividend under its full payout policy. See our latest analysis for Star Bulk Carriers. At a latest share price of US$26.75, the stock has eased in the past week but still shows a strong year to date share price return of 38.1% and a 1 year total shareholder return of 65.52%. This suggests recent momentum remains firmly positive...

In recent weeks, Alignment Healthcare announced that founder and CEO John Kao would also become Chairman while adding senior operators to oversee its management services and operations, alongside being named to the Fortune 1000 list at No. 791. This combination of governance reshaping and Fortune 1000 recognition highlights a maturing organization that is formalizing oversight and operational depth as it scales its senior-focused model. Next, we'll examine how John Kao's expanded role as...

Plexus Corp. recently entered into a Second Amended and Restated Credit Agreement, replacing its 2022 facility with a revolving credit line of up to US$500 million, extendable to US$750 million, and pushing the maturity date out to June 5, 2031. The extended term, larger borrowing capacity and covenant structure tied to leverage and interest coverage ratios give Plexus added financial flexibility that could influence how it funds operations, acquisitions and global expansion over the coming...

Expeditors International of Washington recently cut 230 technology jobs in the Seattle area, with CEO Daniel Wall linking the reductions to automation and new digital tools that are reshaping operations. This shift highlights how Expeditors is reconfiguring its workforce and cost base around automation, even as the broader trade and compliance landscape becomes more complex. Next, we will examine how Expeditors’ push toward automation-led efficiency reshapes its investment narrative for...

Insulet recently used the American Diabetes Association’s 86th Scientific Sessions to unveil new clinical data on its investigational Omnipod 6 and fully closed-loop system for type 2 diabetes, alongside FDA-cleared algorithm upgrades and new sensor compatibility for its commercial Omnipod 5 platform. The trials suggest Omnipod 6 can improve glucose control even with fewer manual boluses, while the type 2 fully closed-loop system delivered better time in range with reduced insulin use and...

Why Burlington Stores stock is back in focus Burlington Stores (BURL) is back on investors’ radar after reporting fiscal Q1 2027 results that included higher earnings, stronger sales, better margins and an increase to full year sales guidance. See our latest analysis for Burlington Stores. The strong Q1 results, higher full year sales guidance and ongoing store expansion have gone hand in hand with a 6.5% 30 day share price return and a 34.4% 1 year total shareholder return. This points to...

Investor attention around Madison Square Garden Entertainment (MSGE) has picked up as the New York Knicks' NBA Finals run focuses the spotlight on MSG linked stocks and possible future moves such as spin offs and overseas growth. See our latest analysis for Madison Square Garden Entertainment. The recent Knicks spotlight and Penn Station redevelopment agreement sit alongside a 30 day share price return of 10.91% and a year to date share price return of 33.22%. The 1 year total shareholder...

Event driven move in Frontline after dividend hike Frontline (FRO) increased its dividend payout after reporting its highest adjusted quarterly profit since 2004, as Iran related disruptions in the Strait of Hormuz reshaped crude shipping routes and pushed tanker earnings higher. See our latest analysis for Frontline. Frontline’s share price has pulled back around 8.2% over the past month but is still up 8.3% over 90 days and 76.2% year to date. Its 5 year total shareholder return of 494.8%...

In early June 2026, Intuit completed two fixed-rate, senior unsecured bond offerings totaling about US$1.75 billion, while simultaneously advancing AI-powered product features such as Mailchimp’s new Analytics AI and preparing for multiple investor conference presentations. At the same time, Intuit has faced pricing scrutiny around TurboTax and a securities fraud investigation, highlighting tension between its AI-led innovation narrative and investor concerns about competitive pressure and...

In early June 2026, uniQure disclosed that the FDA had rejected its data package for accelerated approval of AMT-130 in Huntington’s disease, instead advising a new, lengthy Phase III sham-controlled trial that will delay any potential path to market. This shift forces uniQure to reconsider the role of AMT-130 as its lead value driver, given the extended timelines, higher costs, and added clinical and regulatory uncertainty. We’ll now examine how the FDA’s push for a new Phase III...

American Financial Group (AFG) recently reported core net operating earnings per share rising 17% year over year, beating consensus estimates. The company also declared a US$1.50 special dividend that highlights its current capital strength. See our latest analysis for American Financial Group. At a share price of US$131.28, AFG’s recent price action has been relatively steady, with a 7 day share price return of 1.94% and a 90 day share price return of 3.13%. The 1 year total shareholder...

Stock performance snapshot and recent context Revolve Group (RVLV) has seen mixed share performance recently, with the stock up 3.7% over the past day and 5.8% over the past week, but down over the past month and past 3 months. Year to date the stock is down 31.4%, with the 1 year total return down 7.1%. Over longer periods, the 3 year total return is 20.6%, while the 5 year total return is down 63.1%. At the last close of US$20.27, Revolve Group carries a market value of about US$1.4b. The...

Compañía de Minas Buenaventura S.A.A. has recently benefited from a broad upswing in global metals prices, particularly copper, silver, and gold, while advancing its Peruvian asset base with projects such as the Yumpag mine, expected to lift silver output from 2025. This combination of stronger commodity pricing and mine expansion plans has brought renewed attention to Buenaventura as a leveraged play on cyclical metals exposure and long-term copper and silver demand. We’ll now examine how...

Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare Advantage payment rates. See our latest analysis for Elevance Health. The recent earnings beat and higher 2026 EPS guidance have coincided with strong momentum, with Elevance Health’s 90 day share price return of 46.46% and a 1 year total shareholder return of 12.87% suggesting sentiment has...

Why Li Auto’s May deliveries matter for the stock Li Auto (NasdaqGS:LI) released May 2026 delivery data that fell short of investor expectations, as units declined from April and the prior year, while Chinese EV price competition and changing incentives weighed on sentiment. See our latest analysis for Li Auto. The May delivery shortfall and softer second quarter guidance have come alongside a share price of $14.11, with the stock down 21.61% on a 1 month share price return basis and total...

In early June 2026, Hasbro Inc. launched Sixth Wall, an AI studio that uses proprietary CharacterOS technology and a partnership with ElevenLabs to license how iconic characters like Optimus Prime and Mr. Potato Head think, speak, and interact across interactive experiences. By introducing Behavioral Licensing and a formal talent participation model, Hasbro is seeking to protect character authenticity and rights while opening new AI-driven commercial uses for its franchises. Next, we’ll...

Short term and recent performance snapshot Alliant Energy (LNT) has drawn attention after a recent positive day, with the stock closing at $72.37, up about 0.9% over the past day and almost 2% over the past week. Over the past month the stock shows a gain of about 0.9%, and over the past 3 months it is up roughly 2.2%. Year to date, the total return figure provided is 10.3%, with a 1 year total return of 22.6%. See our latest analysis for Alliant Energy. The recent 1 day share price return of...